US2007238756A1PendingUtilityA1

Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus

Assignee: ARCH JONATHAN R SPriority: Jun 19, 2000Filed: Jun 5, 2007Published: Oct 11, 2007

Est. expiryJun 19, 2020(expired)· nominal 20-yr term from priority

Inventors:Jonathan Arch James Martin Lenhard

A61P 3/06A61P 3/10A61K 31/427A61K 45/06A61K 31/44A61P 3/00A61K 31/425

PatentIndex Score

Cited by

References

Claims

Abstract

A method for the treatment of diabetes mellitus, especially Type 2 diabetes and conditions associated with diabetes mellitus in a mammal such as a human, which method comprises administering an effective, non-toxic and pharmaceutically acceptable amount of a dipeptidyl peptidase IV inhibitor and another antidiabetic agent, to a mammal in need thereof.

Claims

exact text as granted — not AI-modified

1 . A method for the treatment of Type 2 diabetes mellitus and conditions associated therewith in a mammal comprising administering: 
 a dipeptidyl peptidase IV inhibitor; and    5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione or a salt thereof.    
   
   
       2 . A pharmaceutical composition comprising: 
 a dipeptidyl peptidase IV inhibitor;    5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione or a salt thereof; and    one or more pharmaceutically acceptable carrier.    
   
   
       3 . A combination comprising: 
 a dipeptidyl peptidase IV inhibitor; and    5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione or a salt thereof.

Join the waitlist — get patent alerts

Track US2007238756A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.